Market Research Logo

Europe Renal Cell Carcinoma Epidemiology and Patient Flow Analysis - 2017

Europe Renal Cell Carcinoma Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Renal Cell Carcinoma patients study in a new report ‘Europe Renal Cell Carcinoma Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Renal Cell Carcinoma epidemiology, Renal Cell Carcinoma diagnosed patients, and Renal Cell Carcinoma treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Renal Cell Carcinoma derived from epidemiological analysis, percentage of patients diagnosed with Renal Cell Carcinoma, and percentage of patients treated with a therapy.

The study helps executives estimate Renal Cell Carcinoma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Renal Cell Carcinoma prevalence, Renal Cell Carcinoma diagnosis rate, and Renal Cell Carcinoma treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Renal Cell Carcinoma Patient Flow
  • Renal Cell Carcinoma Prevalence
  • Renal Cell Carcinoma Diagnosed Patients
  • Renal Cell Carcinoma Treated Patients


1. Renal Cell Carcinoma: Disease Definition
2. Renal Cell Carcinoma Patient Flow in Europe
2A. Renal Cell Carcinoma Prevalence in Europe
2B. Renal Cell Carcinoma Diagnosed Patients in Europe
2C. Renal Cell Carcinoma Treated Patients in Europe
3. Renal Cell Carcinoma Patient Flow in Germany
3A. Renal Cell Carcinoma Prevalence in Germany
3B. Renal Cell Carcinoma Diagnosed Patients in Germany
3C. Renal Cell Carcinoma Treated Patients in Germany
4. Renal Cell Carcinoma Patient Flow in France
4A. Renal Cell Carcinoma Prevalence in France
4B. Renal Cell Carcinoma Diagnosed Patients in France
4C. Renal Cell Carcinoma Treated Patients in France
5. Renal Cell Carcinoma Patient Flow in Spain
5A. Renal Cell Carcinoma Prevalence in Spain
5B. Renal Cell Carcinoma Diagnosed Patients in Spain
5C. Renal Cell Carcinoma Treated Patients in Spain
6. Renal Cell Carcinoma Patient Flow in Italy
6A. Renal Cell Carcinoma Prevalence in Italy
6B. Renal Cell Carcinoma Diagnosed Patients in Italy
6C. Renal Cell Carcinoma Treated Patients in Italy
7. Renal Cell Carcinoma Patient Flow in UK
7A. Renal Cell Carcinoma Prevalence in UK
7B. Renal Cell Carcinoma Diagnosed Patients in UK
7C. Renal Cell Carcinoma Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Renal Cell Carcinoma Patient Flow in Europe, 2016
Table 2: Renal Cell Carcinoma Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Renal Cell Carcinoma Patient Flow in Germany, 2016
Table 4: Renal Cell Carcinoma Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Renal Cell Carcinoma Patient Flow in France, 2016
Table 6: Renal Cell Carcinoma Patient Flow Forecast in France, 2016 - 2025
Table 7: Renal Cell Carcinoma Patient Flow in Spain, 2016
Table 8: Renal Cell Carcinoma Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Renal Cell Carcinoma Patient Flow in Italy, 2016
Table 10: Renal Cell Carcinoma Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Renal Cell Carcinoma Patient Flow in UK, 2016
Table 12: Renal Cell Carcinoma Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Renal Cell Carcinoma Patient Flow in Europe, 2016
Figure 2: Renal Cell Carcinoma Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Renal Cell Carcinoma Patient Flow in Germany, 2016
Figure 4: Renal Cell Carcinoma Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Renal Cell Carcinoma Patient Flow in France, 2016
Figure 6: Renal Cell Carcinoma Patient Flow Forecast in France, 2016 - 2025
Figure 7: Renal Cell Carcinoma Patient Flow in Spain, 2016
Figure 8: Renal Cell Carcinoma Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Renal Cell Carcinoma Patient Flow in Italy, 2016
Figure 10: Renal Cell Carcinoma Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Renal Cell Carcinoma Patient Flow in UK, 2016
Figure 12: Renal Cell Carcinoma Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report